Health Care Law

HB Ad Slot
HB Mobile Ad Slot

Healthcare law is constantly changing, especially in today’s data driven online world.  Healthcare providers have unprecedented concerns related to privacy and cybersecurity as different technologies and threats intersect in ways never seen before.  With the growth of cloud computing and electronic health records, more regulations and greater scrutiny has been given to the industry, as hospitals, medical providers and healthcare agencies are liable in new and different ways.

The National Law Review covers all legal aspects of the healthcare industry, with expert legal analysis on HIPAA regulations, non-profit organization status, to home health and nursing care abuse.   Additionally, the National Law Review covered all aspects of the Affordable Care Act, or Obamacare, and its implementation, as well as the various attempts to repeal the ACA and new legislation in the healthcare arena, including the American Health Care Act of 2017.

Visitors can read about the US Department of Health and Human Services (HHS), the Office for Civil Rights (OCR), and regulations being promulgated by the Food and Drug Administration (FDA). The Center for Medicare & Medicaid Services (CMS) is also frequently discussed as it relates to drug pricing plans and premiums, new insurance policy requirements and other industry norms.

A major issue in healthcare is the prominence of Ransomware attacks and other cybersecurity concerns, as they relate to patient protected information and HIPAA compliance.  Healthcare systems wanting to maintain compliance with HIPAA regulations and protect patient privacy can find legal analysis and information on how to do so.

Additionally, the rise of Telehealth initiatives in a variety of areas is another area covered by the National Law Review.  With these new technologies, there is a lot of opportunity for innovation, however, careful understanding of telehealth legislation, reimbursement policies and regulations is essential to maintain a standard of care and avoid litigation.

Hospice care, the opioid epidemic, Medicare reimbursement, and issues with antitrust when healthcare systems merge are among the news stories covered by the National Law Review.  Visitors will consistently find updated stories on regulating medical devices, new life sciences technologies, and legislative developments in the healthcare arena. Because the industry is ever-changing, the National Law Review always has new content related to healthcare law.

National Law Review Healthcare Law XFor hourly updates in the latest news about Healthcare & Health Management law, regulations, and legislation, be sure to follow our Health Law X (formerly Twitter) feed, and sign up here for our daily complimentary e-news bulletins.

Recent Health Care, Medicare, ACA, HIPAA & OIG Law News

Title
Custom text Organization
Aug
31
2020
ITC to Investigate Supply Chain Challenges of COVID-19 Products Faegre Drinker
Aug
31
2020
CMS Extends Timeline for Finalizing Changes to Physician Self-Referral (Stark) Law Regulations to August 2021 Robinson & Cole LLP
Aug
31
2020
Indictment of Pharmacy Marketer Reveals Unsuccessful Efforts to Conceal Kickbacks Mintz
Aug
28
2020
COVID-19: US State Policy Report – August 28, 2020 Squire Patton Boggs (US) LLP
Aug
28
2020
OCR Issues New HIPAA Guidance for Covered Entities Contacting Recovered COVID-19 Patients for Plasma Donations McDermott Will & Emery
Aug
28
2020
COVID-19 Weekly Newsletter: CDC Changes Guidance, U.S. Case Trends and New Scientific Developments Faegre Drinker
Aug
28
2020
CMS Establishes New COVID-19 Testing and Reporting Requirements Norris McLaughlin P.A.
Aug
28
2020
Post-Bostock Ruling Does Little to Resolve Health Plan Uncertainty Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Aug
27
2020
CMS Announces One-Year Delay in Finalizing Highly Anticipated Stark Law Reform Mintz
Aug
27
2020
Puerto Rico Health Department Adopts Additional Measures to Manage COVID-19 Pandemic Jackson Lewis P.C.
Aug
27
2020
CDC Updates Guidance on Travel During the COVID-19 Pandemic Proskauer Rose LLP
Aug
27
2020
COVID-19: Employment Issues in Health Care Mergers & Acquisitions in the Era of COVID-19 K&L Gates
Aug
27
2020
Episode 12: Personalized Medicine, the Health Care of the Future [PODCAST] Foley & Lardner LLP
Aug
27
2020
Announced Changes at the Antitrust Division May Presage Greater Enforcement in Health Care Epstein Becker & Green, P.C.
Aug
27
2020
Does Payer Coverage Drive Genomic Test Utilization in the United States? Foley & Lardner LLP
Aug
27
2020
HHS Eases Federal Substance Use Disorder Confidentiality Rules Squire Patton Boggs (US) LLP
Aug
26
2020
EPA Announces Approval of First-Ever Long-Lasting Antiviral Product for Use against COVID-19 Bergeson & Campbell, P.C.
Aug
26
2020
Bioethics in a Pandemic: The Basics Mintz
Aug
26
2020
Opposition to Expansion of Non-Physician Practitioner Scope of Practice Drives Changes to 2021 Inpatient Rehabilitation Facility Prospective Payment System Final Rule Sheppard, Mullin, Richter & Hampton LLP
Aug
26
2020
When Safety Doesn’t Come First: CareOne Nursing Homes & COVID Stark & Stark
Aug
26
2020
The Scope-of-Practice Debate Takes Center Stage: The 2021 Medicare Inpatient Rehabilitation Facility Prospective Payment System Final Rule” Sheppard, Mullin, Richter & Hampton LLP
Aug
26
2020
Getting to Know NASCO: State Charity Officials, Your Mission and Your Board [Podcast] McDermott Will & Emery
Aug
26
2020
Tenth Circuit Interpretation of ERISA Notice Requirement Impacts Plan Administrator’s Right to Deferential Standard of Review Faegre Drinker
Aug
25
2020
Seventh Circuit Adds to Circuit Split Over Standard for DOJ Dismissals in FCA Cases Mintz
Aug
25
2020
In Agency First, EPA Allows Limited Use of Antiviral Disinfectant with Long-Lasting Efficacy Claims Beveridge & Diamond PC
Aug
25
2020
Physician Enterprises After COVID-19: Capturing and Assessing Opportunities [WEBINAR]
Aug
25
2020
OCR Updates Guidance to Clarify That Health Plans May Contact Recovered COVID-19 Patients About Plasma Donation Mintz
Aug
24
2020
HSS Rescinds FDA's "Informal" Ability to Require Premarket Review pf LDTS Without Formal Rulemaking McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins